James Smith

2.0k total citations
38 papers, 981 citations indexed

About

James Smith is a scholar working on Molecular Biology, Economics and Econometrics and Small Animals. According to data from OpenAlex, James Smith has authored 38 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Economics and Econometrics and 5 papers in Small Animals. Recurrent topics in James Smith's work include Animal Behavior and Welfare Studies (5 papers), Biomedical Ethics and Regulation (4 papers) and Pluripotent Stem Cells Research (4 papers). James Smith is often cited by papers focused on Animal Behavior and Welfare Studies (5 papers), Biomedical Ethics and Regulation (4 papers) and Pluripotent Stem Cells Research (4 papers). James Smith collaborates with scholars based in United Kingdom, United States and Australia. James Smith's co-authors include G. M. Cronin, David Brindley, M.R. Bedford, H.V. Masey O’Neill, T.H. McCallum, Georg A. Holländer, Daniel Prieto‐Alhambra, Andrew Carr, Jennifer Camaradou and Andrew Carr and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

James Smith

37 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Smith United Kingdom 18 318 291 193 148 130 38 981
Harendra Kumar India 17 110 0.3× 159 0.5× 100 0.5× 184 1.2× 53 0.4× 154 1.0k
Jennifer A. Larsen United States 19 84 0.3× 286 1.0× 216 1.1× 207 1.4× 25 0.2× 63 1.1k
David G. Bristol United States 17 73 0.2× 217 0.7× 57 0.3× 48 0.3× 28 0.2× 41 964
Esther Mahabir Germany 15 61 0.2× 67 0.2× 300 1.6× 125 0.8× 21 0.2× 54 751
Min‐Kyu Kim South Korea 19 98 0.3× 50 0.2× 452 2.3× 248 1.7× 65 0.5× 72 1.3k
Yong‐Min Kim South Korea 18 118 0.4× 21 0.1× 220 1.1× 152 1.0× 26 0.2× 69 1.1k
Margaret White United States 29 415 1.3× 182 0.6× 689 3.6× 333 2.3× 50 0.4× 93 2.0k
Tracy L. Stevens United States 23 35 0.1× 32 0.1× 354 1.8× 59 0.4× 145 1.1× 34 2.3k
Hiroyuki Izumi Japan 19 34 0.1× 21 0.1× 281 1.5× 68 0.5× 66 0.5× 66 1.1k
Arthur Wang United States 19 22 0.1× 39 0.1× 390 2.0× 112 0.8× 84 0.6× 52 1.2k

Countries citing papers authored by James Smith

Since Specialization
Citations

This map shows the geographic impact of James Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Smith more than expected).

Fields of papers citing papers by James Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Smith. The network helps show where James Smith may publish in the future.

Co-authorship network of co-authors of James Smith

This figure shows the co-authorship network connecting the top 25 collaborators of James Smith. A scholar is included among the top collaborators of James Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Smith. James Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeVito, Nicholas, Jessica Morley, James Smith, et al.. (2024). Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study. SHILAP Revista de lepidopterología. 3(1). e000738–e000738. 7 indexed citations
2.
Lübbeke, Anne, Christophe Combescure, Christophe Baréa, et al.. (2023). Clinical investigations to evaluate high-risk orthopaedic devices: a systematic review of the peer-reviewed medical literature. EFORT Open Reviews. 8(11). 781–791. 5 indexed citations
3.
Smith, James, et al.. (2023). Estimating the effect of COVID-19 on trial design characteristics: a registered report. Royal Society Open Science. 10(1). 201543–201543. 2 indexed citations
4.
Smith, James & Jonas B. Sandbrink. (2022). Biosecurity in an age of open science. PLoS Biology. 20(4). e3001600–e3001600. 20 indexed citations
5.
Carr, Andrew, James Smith, Jennifer Camaradou, & Daniel Prieto‐Alhambra. (2021). Growing backlog of planned surgery due to covid-19. BMJ. 372. n339–n339. 68 indexed citations
6.
Smith, James, Roxanna E. Abhari, Zain Hussain, et al.. (2020). Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study. BMJ Open. 10(10). e039969–e039969. 12 indexed citations
7.
Smith, James. (2020). Development Of A New Mechanical Engineering Program In A Time Of Change. Papers on Engineering Education Repository (American Society for Engineering Education). 13.410.1–13.410.6.
8.
Smith, James, et al.. (2018). The Reporting Items for Patent Landscapes statement. Nature Biotechnology. 36(11). 1043–1047. 28 indexed citations
9.
Moore, Dennis, et al.. (2018). Development of the Progressive Employment dual customer modelfor vocational rehabilitation. Journal of Vocational Rehabilitation. 49(2). 149–160. 4 indexed citations
10.
Smith, James, et al.. (2017). Regulatory Considerations for Gene Therapy Products in the US, EU, and Japan.. PubMed. 90(4). 683–693. 24 indexed citations
11.
Smith, James, et al.. (2017). CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape. Molecular Therapy. 26(2). 342–353. 89 indexed citations
12.
Davies, Benjamin M., James Smith, Anna French, et al.. (2017). An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol. Systematic Reviews. 6(1). 120–120. 8 indexed citations
13.
Smith, James, et al.. (2017). Evidence of insufficient quality of reporting in patent landscapes in the life sciences. Nature Biotechnology. 35(3). 210–214. 9 indexed citations
14.
Smith, James, Wen‐Hwa Lee, Benjamin M. Davies, et al.. (2016). Open Access Could Transform Drug Discovery: A Case Study of JQ1. Expert Opinion on Drug Discovery. 11(3). 321–332. 21 indexed citations
15.
Smith, James, Anna Schuh, Benjamin M. Davies, et al.. (2016). A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics. Frontiers in Genetics. 6. 104–104. 11 indexed citations
16.
Wartolowska, Karolina, Benjamin G. Feakins, Gary S. Collins, et al.. (2016). The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. Trials. 17(1). 589–589. 36 indexed citations
17.
Dahéron, Laurence, Richard Barker, Andrew Carr, et al.. (2015). Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies. Cell stem cell. 16(1). 13–17. 46 indexed citations
18.
O’Neill, H.V. Masey, James Smith, & M.R. Bedford. (2014). Multicarbohydrase Enzymes for Non-ruminants. Asian-Australasian Journal of Animal Sciences. 27(2). 290–301. 107 indexed citations
19.
Smith, James. (1994). "Artificial Conscience": Professional Elites and Professional Discipline from 1920 to 1950. Osgoode Hall law journal. 32(1). 65–97. 1 indexed citations
20.
Smith, James, et al.. (1993). Respiratory arrest following intramuscular ketamine injection in a 4-year-old child. Annals of Emergency Medicine. 22(3). 613–615. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harendra Kumar Breakdown of academic impact, for papers by Jennifer A. Larsen Breakdown of academic impact, for papers by David G. Bristol Breakdown of academic impact, for papers by Esther Mahabir Breakdown of academic impact, for papers by Min‐Kyu Kim Breakdown of academic impact, for papers by Yong‐Min Kim Breakdown of academic impact, for papers by Margaret White Breakdown of academic impact, for papers by Tracy L. Stevens Breakdown of academic impact, for papers by Hiroyuki Izumi Breakdown of academic impact, for papers by Arthur Wang
Rankless by CCL
2026